Molecular phenotyping of circulating tumour cells in patients with prostate cancer: Prediction of distant metastases

BJU International

Volumn 110, Issue 11 C, 2012, Pages

  Giesing, Michael ^a,b   Driesel, Gerhard ^a   Molitor, Dietmar ^c   Suchy, Bernhard ^a  

^a Institute for Molecular Nanotechnology   (Germany)

^b Onkokonsult ^*  (Germany)

^c Vinzentius Krankenhaus   (Germany)

Author keywords

Antioxidant genes; Cancer cell clusters; Epithelial cells; Hormone refractory PCa; Metastatic expression profile; Predictors of metastases

Indexed keywords

DOCETAXEL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; DNA; TUMOR MARKER;

ADULT; AGED; AR GENE; ARTICLE; BFGF GENE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL AGGREGATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CYCLIN B GENE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GPX1 GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SOD2 GENE; SURVIVAL TIME; TREATMENT OUTCOME; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; GERMANY; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROSTATE TUMOR; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR EMBOLISM;

AGED; AGED, 80 AND OVER; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84873265930     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11534.x     Document Type: Article

References (20)

1. Inoue T, Segawa T, Kamba T et al . Prevalence of skeletal complications and their impact on survival of hormone refractory prostate cancer patients in Japan . Urology 2009; 73: 1104-9
2. Saad F, Clarke N, Colombel M . Natural history and treatment of bone complications in prostate cancer . Eur Urol 2006; 49: 429-40 (Pubitemid 43259549)
3. Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M, Patel HR . The metastatic cascade in prostate cancer . Surg Oncol 2006; 15: 117-28 (Pubitemid 46241866)
4. Giesing M, Suchy B, Driesel G, Molitor D . Clinical Utility of the molecular characterizaton of circulating cancer cell clusters and epithelial cells for the detection of prostate cancer in patients with PSA levels of 4-10 ng/ml and postsurgical disease prognostication . BJU Int 2010; 105: 1000-10
5. Helo P, Cronin AM, Danila DC et al . Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival . Clin Chem 2009; 55: 765-73
6. Davis JW, Nakanishi H, Kumar VS et al . Circulating tumor cells in peripherial blood samples from patients with increased serum prostate specifi c antigen: initial results in early prostate cancer . J Urol 2008; 179: 2187-91
7. Suchy B, Austrup F, Driesel G et al . Detection of mammaglobin expressing cells in blood of breast cancer patients . Cancer Lett 2000; 158: 171-8
8. Austrup F, Uciechowski P, Eder C et al . Prognostic value of genomic alterations in minimal residual cancer cells purifi ed from blood of breast cancer patients . Br J Cancer 2000; 83: 1664-73 (Pubitemid 32001712)
9. Gouaze V, Andrieu-Abadie N, Cuvillier O et al . Glutathione peroxidase-1 protects from CD95-induced apoptosis . J Biol Chem 2002; 277: 42867-74 (Pubitemid 35285663)
10. Hsieh CL, Cai C, Giwa A et al . Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells . J Mol Endocrinol 2008; 41: 13-23
11. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T . Amplifi cation and overexpression of androgen receptor gene in hormonerefractory prostate cancer . Cancer Res 2001; 61: 3550-5 (Pubitemid 32694958)
12. Brown RS, Edwards J, Dogan A et al . Amplifi cation of the androgen receptor gene in bone metastases from hormonerefractory prostate cancer . J Pathol 2002; 198: 237-44 (Pubitemid 35243882)
13. Urbanucci A, Waltering KK, Suikki HE, Helenius MA, Visakorpi T . Androgen regulation of the androgen receptor coregulators . B MC Cancer 2008; 8: 219
14. Gregory CW, Johnson RT, Presnell SC, Mohler JL, French FS . Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft . J Androl 2001; 22: 537-48 (Pubitemid 32623073)
15. Gomez LA, de Las Pozas A, Reiner T, Burnstein K, Perez-Stable C . Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy . Mol Cancer Ther 2007; 6: 1534-43 (Pubitemid 46954020)
16. Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de Torres I . Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues . Histol Histopathol 2006; 21: 857-65 (Pubitemid 44082728)
17. Kwabi-Addo B, Ozen M, Ittmann M . The role of fi broblast growth factors and their receptors in prostate cancer . Endocr Relat Cancer 2004; 11: 709-24 (Pubitemid 40065546)
18. Gan Y, Wientjes MG, Au JL . Expression of basic fi broblast growth factor correlates with resistance to paclitaxel in human patient tumors . Pharm Res 2006; 23: 1324-31 (Pubitemid 43946154)
19. D ' Antonio JM, Ma C, Monzon FA, Pfl ug BR . Longitudinal analysis of androgen deprivation of prostate cancer cells identifi es pathways to androgen independence . P rostate 2008; 6 8: 698-714 (Pubitemid 351632942)
20. Donkena KV, Yuan H, Young CY . Recent advances in understanding hormonal therapy resistant prostate cancer . Curr Cancer Drug Targets 2010; 10: 402-10